[1] Jang KA, Choi JH, Sung K J, et al. The hyperkeratotic variant of disseminated superficial actinic porokeratosis (DSAP). Int JDermatol, 1999, 38: 204-206.
[2] Rongioletti F, Rebora A. Disseminatedporokeratosis with fatal metastatic squamous cell carcinoma: an additional case of"malignant disseminated porokeratosis".Am J Dermatopathol, 2002, 24: 144-148.
[3] 张学奇,杨森,郭勇,等.五个汗孔角化病家系的临床和遗传特点.中华皮肤科杂志,2003,36:549-552
[4] Xia JH, Yang YF, Deng H, et al. Identification of a locus for disseminated superfi cial actinic porokeratosis at chromosome 12q23.2-24.1. J Invest Dermatol, 2000, 114: 1071-1074.
[5] Allen AL, Glaser DA. Disseminated super ficial actinic porokeratosis associated with topical PUVA. J Am Acad Dermatol, 2000, 43: 720-722.
[6] 张学奇,张学军,杨森,等.掌跖及泛发性汗孔角化症一家系报道.临床皮肤科杂志,2002,31:650-652.
[7] Brodkin RH, Rickert RR, Fuller FW, et al. Malignant disseminated porokeratosis. Arch Dermatol, 1987, 123: 1521-1526.
[8] Seishima M, Izumi T, Oyama Z, et al. Squamous cell carcinoma arising from le sions of porokeratosis palmaris et plantaris disseminata. Eur J Dermatol, 2000, 10: 478-480.
[9] 林达,张学奇,张学军,等一家系10例线性经典斑块型汗孔角化症.中华皮肤科杂志,2003,36:477.
[10] Happle R. Cancer proneness of linear porokeratosis may be explained by allelic loss. Dermatology, 1997, 195:20-25.
[11] Hunt SJ, Sharra WG, Abell E. Linear and punctate porokeratosis associated with end-stage liver disease. J Am Acad Der matol, 1991, 25:937-939.
[12] Jurecka W, Neumann RA, Knobler RM. Porokeratoses: immunohistochemical, light and electron microscopic evaluation. J Am Acad Dermatol, 1991, 24:96-101.
[13] Anzai S, Takeo N, Yamaguchi T, et al. Squamous cell carcinoma in a renal trans plant recipient with linear porokeratosis. J Dermatol, 1999, 26: 244-247.
[14] Rio B, Magana C, Le Tourneau A, et al. Disseminated superficial porokeratosis after autologous bone marrow transplantation. Bone Marrow Transplant, 1997, 19: 77-79.
[15] Mizukawa Y, Shiohara T. Porokeratosis in patients with hepatitis C virus infection: does hepatitis C virus infection provide a link between porokeratosis and immuno suppression? Br J Dermatol, 1999, 141: 163-164.
[16] Schamroth JM, Zlotogorski A, Gilead L. Porokeratosis of Mibelli. Overview and re view of the literature. Acta Derm Venereol, 1997, 77:207-213.
[17] Xia K, Deng H, Xia JH, et al. A novel lo cus (DSAP2) for disseminated superficial actinic porokeratosis maps to chromosome 15q25.1-26.1. Br J Dermatol, 2002, 147: 650-654.
[18] Wei SC, Yang S, Li M, et al. Identifica tion of a locus for porokeratosis palmaris et plantaris disseminata to a 6.9-cM region at chromosome 12q24.1-24.2. Br J Der matol, 2003, 149: 261-267.
[19] Bhushan M, Craven NM, Beck MH, et al. Linear porokeratosis of mibelli: successful treatment with cryotherapy. Br J Dermatol, 1999, 141:389.
[20] Groot DW, Johnston PA. Carbon dioxide laser treatment of porokeratosis of Mibelli. Lasers Surg Med, 1985, 5:603-606.
[21] Alster TS, Nanni CA. Successful treatment of porokeratosis with 585 nm pulsed dye laser irradiation. Cutis, 1999, 63: 26526.
[22] Sander CA, Pfeiffer C, Kligman AM, et al. Chemotherapy for disseminated actiuic keratoses with 5 -fllurouracil and isotretinoin. J Am Acad Dermatol, 1997, 36: 236-238.
[23] Bohm M, Luger TA, Bonsmann G. Dissem inated superficial actinic porokeratosis: treatment with topical tacalcitol. J Am Acad Dermatol, 1999, 40:479-480. |
